Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

2.9K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV-Driven miR-146a Promotes Neurite Outgrowth and Axonal Regeneration in Cortical Neurons.

Journal of neurochemistry·2026
Same author

Pregnant women with periodontal disease: can complete blood count be useful?

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2025
Same author

Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models.

Journal of endocrinological investigation·2021
Same author

Familial hypercholesterolemia: Is there a role for PCSK9 and thrombin generation?

Thrombosis research·2021
Same author

For how long is memory lost in transient global amnesia?

European journal of neurology·2020
Same author

Correction to: G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis.

Journal of neuro-oncology·2019

Related Experiment Video

Updated: Apr 5, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

37.6K

Leptin in Alzheimer's disease.

C A Magalhães1, M G Carvalho1, L P Sousa1

  • 1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|August 18, 2015
PubMed
Summary

Leptin, a hormone from fat tissue, may predict dementia risk and offer neuroprotection. Evaluating leptin levels could improve understanding and management of Alzheimer's disease (AD) and other dementias.

Keywords:
Alzheimer's diseaseAmyloid-β proteinLeptinNeuroprotectionTau

More Related Videos

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.4K

Related Experiment Videos

Last Updated: Apr 5, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

37.6K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.4K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is the leading cause of dementia in older adults, characterized by amyloid-β plaques and neurofibrillary tangles.
  • Obesity is increasingly recognized as an independent risk factor for AD, highlighting the importance of adipose tissue in brain health.
  • Understanding the role of hormones like leptin in dementia development is crucial for identifying new diagnostic and therapeutic strategies.

Purpose of the Study:

  • To review existing literature on the role of leptin, a hormone produced by adipocytes, in the context of dementia.
  • To explore leptin's potential as a predictive biomarker for dementia risk and progression.
  • To examine evidence for leptin's neuroprotective effects in Alzheimer's disease.

Main Methods:

  • Systematic review of scientific studies investigating leptin and its association with dementia.
  • Analysis of research exploring leptin's impact on amyloidogenic processes and tau phosphorylation.
  • Evaluation of studies examining leptin's influence on cognitive function in the context of neurodegenerative diseases.

Main Results:

  • Leptin evaluation may serve as a more effective predictor of dementia than traditional anthropometric measures.
  • Leptin has demonstrated potential neuroprotective activities, including inhibition of amyloidogenesis and reduction of tau phosphorylation.
  • Leptin may play a role in improving cognitive function, suggesting a link between metabolic health and brain function.

Conclusions:

  • Leptin holds promise as a biomarker for assessing Alzheimer's disease risk and tracking disease progression.
  • Leptin's neuroprotective properties warrant further investigation for potential therapeutic applications in dementia.
  • Further research into leptin's multifaceted role in brain health is essential for developing effective strategies against dementia.